Paras Healthcare Ltd has raised ₹652.5 crore from anchor investors ahead of its ₹1,450-crore initial public offering (IPO), with participation from domestic mutual funds, global investment institutions and insurance companies.
The company allotted approximately 94.16 lakh equity shares at ₹693 apiece on October 19, according to reported anchor-book disclosures. The anchor allocation comes ahead of the IPO, which opened for public subscription on October 21 and will close on October 23, 2026.
SBI Mutual Fund, HDFC Mutual Fund, ICICI Prudential Mutual Fund, BlackRock Global Funds and the Abu Dhabi Investment Authority (ADIA) were among the reported participants in the anchor book.
Domestic mutual funds received approximately 55.55 lakh shares worth ₹385 crore through 24 schemes, accounting for about 59% of the total anchor investment. Insurance companies, including ICICI Prudential Life Insurance, Edelweiss Life Insurance and Canara HSBC Life Insurance, also participated in the allocation.
Paras Healthcare IPO: Key Anchor Book Details
Particulars | Details |
|---|---|
Total anchor investment | ₹652.5 crore |
Shares allotted | Approximately 94.16 lakh |
Anchor allotment price | ₹693 per share |
Domestic mutual fund allocation | ₹385 crore |
Total IPO size | ₹1,450 crore |
Fresh issue | ₹500 crore |
Offer for sale | ₹950 crore |
Public issue dates | October 21–23, 2026 |
Detailed Institutional Anchor Allotment Breakdown
Paras Healthcare’s pre-IPO anchor allocation demonstrated robust institutional demand, securing ₹652.50 crore through the allotment of 94,15,584 equity shares at the upper price band of ₹693 per share on October 19, 2026. The anchor portion represents 45% of the total ₹1,450-crore issue (and 60% of the Qualified Institutional Buyers' quota), attracting participation from a syndicate of 39 institutional funds spanning domestic asset managers, foreign portfolio investors, sovereign wealth funds, and domestic life insurers.
1. Domestic Mutual Funds: The Primary Anchor (₹385 Crore / 59.0%)
Domestic mutual funds formed the cornerstone of the allocation, absorbing 55,55,100 shares worth ₹385 crore across 24 distinct schemes. This chunk accounted for nearly three-fifths (59.0%) of the total anchor book.
Major AMC Schemes: SBI Mutual Fund emerged as one of the largest anchor takers across multiple vehicles, including the SBI Multi Asset Allocation Fund (₹65 crore / 9.96%), SBI Infrastructure Fund (₹50 crore / 7.66%), and SBI Healthcare Opportunities Fund (₹35 crore / 5.36%).
Participating Fund Houses: Top-tier asset management companies securing allotments included:
SBI Mutual Fund
HDFC Mutual Fund
ICICI Prudential Mutual Fund
Kotak Mahindra Mutual Fund
WhiteOak Capital Mutual Fund
Motilal Oswal Asset Management
Edelweiss Mutual Fund
Baroda BNP Paribas Mutual Fund
ITI Mutual Fund
2. Foreign Institutional Investors & Sovereign Wealth Funds (₹222.5 Crore / 34.1%)
Global institutional investors and Foreign Portfolio Investors (FPIs) locked in approximately 32.12 lakh shares, valued at ₹222.5 crore (representing 34.1% of the anchor book). The international tranche featured marquee sovereign wealth funds and global asset managers:
Sovereign Funds: The Abu Dhabi Investment Authority (ADIA) was the single largest overall anchor applicant, taking 10,10,058 shares worth ₹70 crore (10.73% of the anchor book). Norway’s Government Pension Fund Global also took a significant allocation.
Global Fund Platforms: Additional international participation included BlackRock Global Funds, Eastspring Investments, Natixis International Funds, Integrated Core Strategies (Asia), and Citigroup Global.
3. Domestic Insurance Companies (₹45 Crore / 6.9%)
Domestic life insurance providers picked up 6,49,350 shares, totaling ₹45 crore (6.9% of the anchor book). Leading life insurers in this tranche included:
ICICI Prudential Life Insurance Company (allotted 5,05,050 shares worth ₹35 crore / 5.36% of the book)
Edelweiss Life Insurance
Canara HSBC Life Insurance
Anchor Allocation Summary
Investor Category | Allotted Value (₹ Cr) | Share of Anchor Book (%) | Equity Shares Allotted | Key Participating Entities / Funds |
Domestic Mutual Funds | ₹385.00 | 59.0% | 55,55,100 | SBI, HDFC, ICICI Pru, Kotak, WhiteOak, Motilal Oswal, Edelweiss, Baroda BNP, ITI |
FIIs & Global Institutions | ₹222.50 | 34.1% | ~32,11,134 | ADIA (₹70 Cr), BlackRock, Norway Pension Fund, Eastspring, Natixis, Citi |
Insurance Companies | ₹45.00 | 6.9% | 6,49,350 | ICICI Prudential Life (₹35 Cr), Edelweiss Life, Canara HSBC Life |
Total Anchor Allocation | ₹652.50 | 100.0% | 94,15,584 | 39 Institutional Funds @ ₹693 per share |
Lock-in Mandate & Regulatory Implications
Under SEBI IPO regulations, anchor investors are subject to a phased lock-in schedule:
50% of the anchor shares (approx. 47.08 lakh shares) are locked in for 30 days following allotment (until November 25, 2026).
The remaining 50% of shares are locked in for 90 days (until January 24, 2027).
Paras Healthcare IPO: Issue Structure and Fund Utilisation
The ₹1,450-crore IPO comprises a fresh issue of ₹500 crore and an offer for sale (OFS) of ₹950 crore.
The fresh issue proceeds are intended primarily for debt repayment and general corporate purposes. Of the fresh issue, approximately ₹302.90 crore is earmarked for repayment or prepayment of borrowings at Paras Healthcare, while ₹54.10 crore is allocated to its wholly owned subsidiary for debt reduction.
The OFS component allows existing shareholders to sell shares. Proceeds from this portion will go to the selling shareholders rather than the company.
Hospital Expansion and Earnings Recovery
Paras Healthcare operates eight hospitals across North India, Bihar and Jharkhand, with a combined capacity of 2,211 beds. The company plans to expand its capacity to 3,011 beds by March 2028, including planned additions in Gurugram and Ludhiana.
The company's financial performance improved in FY26, when it reported revenue from operations of ₹1,605.95 crore and profit after tax of ₹43.83 crore, following losses in the previous two financial years.
EBITDA rose to ₹335.58 crore in FY26, with the operating margin improving to approximately 20.9%. Sustaining this improvement while expanding capacity will be an important factor in determining the company's future earnings trajectory.
At the upper price band of ₹693, Paras Healthcare's post-issue market capitalisation is approximately ₹7,498 crore. The implied price-to-earnings multiple is around 171 times based on post-issue FY26 earnings per share of approximately ₹4.05.
The valuation places considerable importance on future earnings growth, effective debt management and the successful commissioning and utilisation of additional hospital capacity.
What Investors Should Watch
While the anchor allocation has attracted several prominent institutional investors, the IPO's investment case will depend on more than the names participating in the anchor book.
Investors will need to assess the sustainability of the FY26 earnings recovery, the company's remaining debt obligations, capital expenditure requirements and its ability to generate adequate returns from planned expansion.
The IPO is scheduled to close on October 23, with allotment tentatively expected on October 26 and listing on October 28, 2026.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. Investors should review the official Red Herring Prospectus and consider the risks associated with the IPO before making investment decisions.
